Cubist Systematic Strategies’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-8,640
| Closed | -$187K | – | 3577 |
|
2022
Q4 | $187K | Buy |
8,640
+4,930
| +133% | +$107K | ﹤0.01% | 2674 |
|
2022
Q3 | $72K | Buy |
+3,710
| New | +$72K | ﹤0.01% | 3275 |
|
2022
Q2 | – | Sell |
-10,975
| Closed | -$327K | – | 4166 |
|
2022
Q1 | $327K | Buy |
10,975
+10,006
| +1,033% | +$298K | ﹤0.01% | 2768 |
|
2021
Q4 | $23K | Buy |
+969
| New | +$23K | ﹤0.01% | 3370 |
|
2020
Q4 | – | Sell |
-7,129
| Closed | -$238K | – | 2770 |
|
2020
Q3 | $238K | Buy |
7,129
+7,103
| +27,319% | +$237K | ﹤0.01% | 2070 |
|
2020
Q2 | $1K | Sell |
26
-8,229
| -100% | -$317K | ﹤0.01% | 2368 |
|
2020
Q1 | $135K | Buy |
+8,255
| New | +$135K | ﹤0.01% | 1838 |
|
2019
Q4 | – | Sell |
-415
| Closed | -$8K | – | 2602 |
|
2019
Q3 | $8K | Sell |
415
-344
| -45% | -$6.63K | ﹤0.01% | 2157 |
|
2019
Q2 | $24K | Buy |
+759
| New | +$24K | ﹤0.01% | 2378 |
|